viastockadvisors

Small cap growth stock expert Jim Oberweis, Jr. sees potential opportunity in CardioNet, a maker of cardiac monitoring systems. Here’s a look from The Oberweis Report.

Track Jim’s picks at:

http://trackthepros.com/stocks/category/1428

“CardioNet is a provider of a cardiac monitoring system that is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, and provides continuous, heartbeat-by- heartbeat monitoring of a patient outside a hospital or care center.

“The company’s CardioNet System is a proprietary and portable patient monitoring platform that incorporates a wireless data transmission network, internally developed software, FDA-cleared algorithms and medical devices, and a 24-hour digital monitoring service center.

“When the monitor detects an arrhythmic event, it automatically transmits the ECG to the CardioNet Monitoring Center, even in the absence of symptoms noticed by the patient and without patient involvement.

“Since the commercial introduction of the CardioNet System in January 2003, physicians have enrolled over 133,000 patients.

“In the company’s latest reported second quarter, sales increased approximately 68% to $29.3 million from $17.4 million in the second quarter of last year.  CardioNet reported earnings per share of $.08 in the latest reported second quarter versus a loss in the same quarter of last year.

“For disclosure, we note that clients of Oberweis Asset Management own approximately 284,000 shares. In our view, these shares may be appropriate for riskoriented investors.”